VIRMA, as another m6A writer, is closely associated with adverse prognosis of ICC patients and promotes proliferation and metastasis of ICC though inducing SIRT1 expression via a mechanism involving m6A modification (Zhou et al., 2023). The gene discussed is SIRT1; the disease is intrahepatic cholangiocarcinoma.